In modified intention-to-treat analysis, time to linkage to care significantly less for people with HIV in intervention group ...
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif., December 22, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly ...
Lenacapavir works by interfering with the virus’s ability to multiply and spread within the body if exposure occurs. It does this by binding to the outer layer of the HIV‑1 virus, preventing the virus ...
Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...
Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's ...
The Hearty Soul on MSN
Man unexpectedly cured from HIV after stem cell transplant
A few decades ago, the idea of an HIV cure sounded unrealistic. Today, doctors describe a carefully documented case where the ...
In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...
Researchers at Johns Hopkins Medicine have reported evidence that standard chemotherapeutic drugs may selectively suppress ...
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...
A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback